These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22054461)

  • 1. [Ki67 and neuroendocrine tumors].
    Couvelard A
    Ann Pathol; 2011 Nov; 31(5 Suppl):S55-6. PubMed ID: 22054461
    [No Abstract]   [Full Text] [Related]  

  • 2. [WHO Classification of digestive tumors: the fourth edition].
    Fléjou JF
    Ann Pathol; 2011 Nov; 31(5 Suppl):S27-31. PubMed ID: 22054452
    [No Abstract]   [Full Text] [Related]  

  • 3. [How to evaluate Ki67].
    Herlin P
    Ann Pathol; 2011 Nov; 31(5 Suppl):S49-51. PubMed ID: 22054459
    [No Abstract]   [Full Text] [Related]  

  • 4. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.
    Rindi G; Klöppel G; Alhman H; Caplin M; Couvelard A; de Herder WW; Erikssson B; Falchetti A; Falconi M; Komminoth P; Körner M; Lopes JM; McNicol AM; Nilsson O; Perren A; Scarpa A; Scoazec JY; Wiedenmann B; ;
    Virchows Arch; 2006 Oct; 449(4):395-401. PubMed ID: 16967267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathologic diagnostic for a primary of metastatic neuroendocrine tumor].
    Leteurtre E
    Ann Pathol; 2011 Nov; 31(5 Suppl):S79-80. PubMed ID: 22054469
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis of (neuro)endocrine tumors: a brief practical review of new classifications and new markers].
    Papotti M; Volante M; Bongiovanni M; Pecchioni C; Bussolati G
    Pathologica; 2000 Dec; 92(6):562-8. PubMed ID: 11234306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuroendocrine tumors of digestive system: morphologic spectrum and cell proliferation (Ki67 index)].
    Delektorskaia VV; Kushliskiĭ NE
    Vestn Ross Akad Med Nauk; 2013; (5):28-37. PubMed ID: 24000665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
    McCall CM; Shi C; Cornish TC; Klimstra DS; Tang LH; Basturk O; Mun LJ; Ellison TA; Wolfgang CL; Choti MA; Schulick RD; Edil BH; Hruban RH
    Am J Surg Pathol; 2013 Nov; 37(11):1671-7. PubMed ID: 24121170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trends in gastroenteropancreatic neuroendocrine tumors].
    Kajiwara H; Osamura Y
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):123-7. PubMed ID: 18536314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognoses of GEP-NETS with undetermined malignant potentials of their primary sites.
    Kudo A; Ban D; Akashi T; Kumagai J; Aihara A; Inokuchi M; Kojima K; Kawano T; Tanaka S; Arii S
    Hepatogastroenterology; 2012 Sep; 59(118):1682-6. PubMed ID: 22584425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The latest 2010 WHO classification of tumors of digestive system].
    Li ZS; Li Q
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):351-4. PubMed ID: 21756837
    [No Abstract]   [Full Text] [Related]  

  • 13. The Influence of Tumor Stage on the Prognostic Value of Ki-67 Index and Mitotic Count in Small Intestinal Neuroendocrine Tumors.
    Sun Y; Lohse C; Smyrk T; Hobday T; Kroneman T; Zhang L
    Am J Surg Pathol; 2018 Feb; 42(2):247-255. PubMed ID: 29016403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices.
    Remes SM; Tuominen VJ; Helin H; Isola J; Arola J
    Am J Surg Pathol; 2012 Sep; 36(9):1359-63. PubMed ID: 22895268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.
    Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F
    Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tissue heterogeneity contributes to suboptimal precision of WHO 2010 scoring criteria for Ki67 labeling index in a subset of neuroendocrine neoplasms of the pancreas].
    Liszka Ł
    Pol J Pathol; 2016; 67(4):318-331. PubMed ID: 28547959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria.
    Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C
    Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading the neuroendocrine tumors of the lung: an evidence-based proposal.
    Rindi G; Klersy C; Inzani F; Fellegara G; Ampollini L; Ardizzoni A; Campanini N; Carbognani P; De Pas TM; Galetta D; Granone PL; Righi L; Rusca M; Spaggiari L; Tiseo M; Viale G; Volante M; Papotti M; Pelosi G
    Endocr Relat Cancer; 2014 Feb; 21(1):1-16. PubMed ID: 24344249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors.
    Vilar E; Salazar R; Pérez-García J; Cortes J; Oberg K; Tabernero J
    Endocr Relat Cancer; 2007 Jun; 14(2):221-32. PubMed ID: 17639039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.